{"id":104173,"date":"2026-06-10T02:05:09","date_gmt":"2026-06-10T02:05:09","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/104173\/"},"modified":"2026-06-10T02:05:09","modified_gmt":"2026-06-10T02:05:09","slug":"novo-nordisk-ceo-80-of-wegovy-pill-customers-have-never-taken-a-glp-1-before","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/104173\/","title":{"rendered":"Novo Nordisk CEO: &#8216;80% of Wegovy pill customers&#8217; have never taken a GLP-1 before"},"content":{"rendered":"<p>ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email<\/p>\n<p>At the American Diabetes Association\u2019s 2026 Scientific Sessions, CNBC\u2019s Angelica Peebles sat down with Novo Nordisk CEO Mike Doustdar to discuss the launch of the Wegovy pill and how it became the best prescription drug launch in history.<\/p>\n<p>09:12<\/p>\n<p>Tue, Jun 9 20262:26 PM EDT<\/p>\n","protected":false},"excerpt":{"rendered":"ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email At the American Diabetes Association\u2019s&hellip;\n","protected":false},"author":2,"featured_media":104174,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[1275,8729,272,1273,358],"class_list":["post-104173","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-business-news","tag-neutral","tag-novo-nordisk","tag-novo-nordisk-a-s","tag-pharmaceuticals"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116723366384121931","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/104173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=104173"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/104173\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/104174"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=104173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=104173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=104173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}